Hennion & Walsh Asset Management, Inc. Organogenesis Holdings Inc. Transaction History
Hennion & Walsh Asset Management, Inc.
- $2.59 Billion
- Q3 2025
A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 158,740 shares of ORGO stock, worth $719,092. This represents 0.03% of its overall portfolio holdings.
Number of Shares
158,740
Previous 93,407
69.94%
Holding current value
$719,092
Previous $341,000
110.85%
% of portfolio
0.03%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding ORGO
# of Institutions
127Shares Held
71.8MCall Options Held
15.1KPut Options Held
25-
Soleus Capital Management, L.P. Greenwich, CT12.3MShares$55.9 Million3.5% of portfolio
-
Morgan Stanley New York, NY12.1MShares$54.6 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN6.78MShares$30.7 Million3.81% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.2MShares$23.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$23 Million0.0% of portfolio
About Organogenesis Holdings Inc.
- Ticker ORGO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 130,888,000
- Market Cap $593M
- Description
- Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...